Image pharmaphorum Editor News Migraine prevention drug Aimovig poised for EU approval The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval. News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech. News LuViva scanner could provide alternative to smear test Device is 18 months from US approval Load more results
News Migraine prevention drug Aimovig poised for EU approval The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval.
News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial
Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
